Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.160
+0.020 (0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
75
Market Cap
266.90M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 441.03M |
AngioDynamics | 292.73M |
OraSure Technologies | 224.26M |
Poseida Therapeutics | 150.86M |
NeuroPace | 76.45M |
Mersana Therapeutics | 34.84M |
Eton Pharmaceuticals | 34.68M |
Ocugen | 4.70M |
AVIR News
- 5 days ago - Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD's The Liver Meeting 2024 - GlobeNewsWire
- 11 days ago - Atea Pharmaceuticals, Inc. (AVIR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 22 days ago - Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD's The Liver Meeting 2024 - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals Provides Update on Global Phase 3 SUNRISE-3 Trial Evaluating Bemnifosbuvir for Treatment of COVID-19 - GlobeNewsWire
- 3 months ago - Atea Pharmaceuticals Announces Publication of Additional Data Further Highlighting Bemnifosbuvir's Metabolic Activation Pathway - GlobeNewsWire
- 3 months ago - Atea Pharmaceuticals, Inc. (AVIR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - GlobeNewsWire